The SCHD ETF — officially known as the Schwab U.S. Dividend Equity ETF — has become one of the most talked-about investments of 2026. If you follow dividend investing, you have probably heard about SCHD ETF — the Schwab U.S. Dividend Equity ETF. But in 2026, SCHD ETF is not just a quiet income fund sitting in the background. It is one of the hottest investments in the entire market. SCHD ETF’s total return in 2026 has been nothing short of remarkable for dividend investors
As of July 29, 2026, SCHD ETF has registered a total return of 26% year-to-date — nearly
double the S&P 500’s 13% gain over the same period. For a dividend ETF, that is a
remarkable number.
For long-term dividend investors, the SCHD offers a rare combination of income, quality, and growth potential. Let’s break down what is driving this performance and whether SCHD belongs in your long-term dividend portfolio.
What Is the SCHD ETF?
SCHD is the Schwab U.S. Dividend Equity ETF, one of the most popular dividend ETFs in the
world. As of August 2026, it holds $105 billion in assets under management and tracks the
Dow Jones U.S. Dividend 100 Index — a portfolio of 100 carefully selected dividend-paying stocks.
Key facts about SCHD:
- Expense ratio: 0.06% (just $6 per $10,000 invested)
- Trailing 12-month dividend yield: approximately 3.3%
- Number of holdings: 100 stocks
- Minimum dividend history required: 10 consecutive years
Why Is the SCHD ETF Up 26% in 2026?
SCHD’s outperformance in 2026 comes from two key factors.
Quality Screening
SCHD does not simply buy the highest-yielding stocks. Instead, it screens companies based on four fundamental criteria:
- Cash flow-to-debt ratio
- Return on equity
- Dividend yield
- Five-year dividend growth rate
This focus on financial quality means SCHD holds companies with strong balance sheets
and durable cash flows — exactly the kind of businesses that have held up well in the
volatile 2026 market.
Sector Positioning
The top two sectors in SCHD are healthcare and consumer staples, which together account
for approximately 41% of the portfolio. These are traditionally recession-resistant sectors
that have provided stability while growth stocks — particularly technology — have faced headwinds.
SCHD’s top three holdings as of August 2026 are Abbott Laboratories, Amgen, and Merck — all healthcare companies with strong dividend histories and durable competitive advantages.
The 20-Year Case for SCHD
Beyond 2026’s impressive performance, there is a compelling long-term case for holding
SCHD for 20 years or more.
In the past decade alone, SCHD’s dividend payout has more than tripled. That means
investors who bought SCHD 10 years ago are now receiving significantly more income on
their original investment than when they started — without doing anything except holding and reinvesting.
This is the power of dividend growth compounding over time.
What Are the Risks?
No investment is without risk, and SCHD is no exception.
SCHD can underperform in periods when growth stocks dominate the market — which is exactly
what happened from 2021 to 2025, when SCHD delivered modest returns compared to growth-focused funds.
Additionally, no ETF can guarantee it will continue outperforming for decades. Market
conditions change, and dividend stocks can go out of favor just as they have come back
into favor in 2026.
As 247 Wall St analyst Omor Ibne Ehsan notes, SCHD’s thesis could change if future
administrations introduce significant austerity measures — though that scenario
appears unlikely in the current political and fiscal environment.
My Take
I have been watching SCHD closely throughout 2026, and its performance has genuinely
impressed me. But what impresses me most is not the 26% return — it is the consistency
of the underlying strategy.
SCHD’s quality screens have been doing exactly what they were designed to do: filtering out
financially weak companies and keeping the portfolio anchored in businesses with strong
cash flow and growing dividends. That kind of discipline is what creates 20-year
compounding machines.
If you are a beginner dividend investor looking for a core holding, SCHD deserves
serious consideration. Not because of its 2026 performance, but because of what its
portfolio quality says about its long-term potential.
Just remember: past performance does not guarantee future results. Always invest
based on your own financial situation and goals.
Sources
- Neil Patel, The Motley Fool via Yahoo Finance:
“1 Unstoppable Dividend ETF Up 26% in 2026 to Buy and Hold for the Next 20 Years”
(July 31, 2026) - Omor Ibne Ehsan, 247 Wall St: “How $300 a Month in This Dividend ETF Could Make You a Millionaire” (August 24, 2026)
- Schwab Asset Management official fund data
- Data retrieved: August 26, 2026
All yield, performance, and holdings data is approximate and subject to change. Verify current figures at schwab.com/schd before making any investment decisions.
Disclaimer: This article is for educational and informational purposes only and should not be construed as financial or investment advice. Always consult with a qualified financial advisor before making investment decisions. Investing involves risk, including the possible loss of principal.